Oppenheimer Maintains Outperform on Nutrien, Lowers Price Target to $78
Oppenheimer analyst Kristen Owen maintains Nutrien (NYSE:NTR) with a Outperform and lowers the price target from $80 to $78.
Share
Why It Matters
An expert analyst still likes Nutrien but thinks it might be worth a bit less money soon. When experts lower their price targets, it hints the company faces some near-term headwinds.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.